nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—TOP2A—malignant glioma	0.614	1	CbGaD
Levofloxacin—CYP1A2—Carmustine—malignant glioma	0.119	0.57	CbGbCtD
Levofloxacin—CYP3A4—Temozolomide—malignant glioma	0.0897	0.43	CbGbCtD
Levofloxacin—Moxifloxacin—TOP2A—malignant glioma	0.00142	0.209	CrCbGaD
Levofloxacin—Interstitial lung disease—Carmustine—malignant glioma	0.00109	0.00749	CcSEcCtD
Levofloxacin—Interstitial lung disease—Temozolomide—malignant glioma	0.00106	0.00724	CcSEcCtD
Levofloxacin—Influenza-like symptoms—Temozolomide—malignant glioma	0.00105	0.00718	CcSEcCtD
Levofloxacin—Pefloxacin—TOP2A—malignant glioma	0.00104	0.153	CrCbGaD
Levofloxacin—Stupor—Carmustine—malignant glioma	0.00104	0.0071	CcSEcCtD
Levofloxacin—Scotoma—Carmustine—malignant glioma	0.00102	0.00699	CcSEcCtD
Levofloxacin—Menorrhagia—Temozolomide—malignant glioma	0.00101	0.00693	CcSEcCtD
Levofloxacin—Hepatotoxicity—Carmustine—malignant glioma	0.001	0.00687	CcSEcCtD
Levofloxacin—Extrapyramidal disorder—Temozolomide—malignant glioma	0.000992	0.00681	CcSEcCtD
Levofloxacin—Scotoma—Temozolomide—malignant glioma	0.000984	0.00675	CcSEcCtD
Levofloxacin—Enoxacin—TOP2A—malignant glioma	0.000971	0.143	CrCbGaD
Levofloxacin—Hepatotoxicity—Temozolomide—malignant glioma	0.000968	0.00664	CcSEcCtD
Levofloxacin—Coagulopathy—Temozolomide—malignant glioma	0.00096	0.00658	CcSEcCtD
Levofloxacin—Otitis media—Temozolomide—malignant glioma	0.00096	0.00658	CcSEcCtD
Levofloxacin—Hyperaesthesia—Temozolomide—malignant glioma	0.000952	0.00653	CcSEcCtD
Levofloxacin—Injection site pain—Carmustine—malignant glioma	0.000947	0.0065	CcSEcCtD
Levofloxacin—Rigors—Temozolomide—malignant glioma	0.000915	0.00628	CcSEcCtD
Levofloxacin—Petechiae—Temozolomide—malignant glioma	0.000908	0.00623	CcSEcCtD
Levofloxacin—Speech disorder—Carmustine—malignant glioma	0.000899	0.00617	CcSEcCtD
Levofloxacin—Sparfloxacin—TOP2A—malignant glioma	0.000894	0.131	CrCbGaD
Levofloxacin—Speech disorder—Temozolomide—malignant glioma	0.000869	0.00596	CcSEcCtD
Levofloxacin—Drug interaction—Carmustine—malignant glioma	0.000834	0.00572	CcSEcCtD
Levofloxacin—Viral infection—Temozolomide—malignant glioma	0.000827	0.00568	CcSEcCtD
Levofloxacin—Leukocytosis—Carmustine—malignant glioma	0.000823	0.00564	CcSEcCtD
Levofloxacin—Herpes simplex—Temozolomide—malignant glioma	0.000811	0.00556	CcSEcCtD
Levofloxacin—Gait disturbance—Carmustine—malignant glioma	0.000792	0.00543	CcSEcCtD
Levofloxacin—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00079	0.00542	CcSEcCtD
Levofloxacin—Coordination abnormal—Carmustine—malignant glioma	0.000787	0.0054	CcSEcCtD
Levofloxacin—Hearing impaired—Temozolomide—malignant glioma	0.000785	0.00539	CcSEcCtD
Levofloxacin—Pulmonary embolism—Carmustine—malignant glioma	0.000773	0.0053	CcSEcCtD
Levofloxacin—Injection site reaction—Carmustine—malignant glioma	0.000769	0.00527	CcSEcCtD
Levofloxacin—Gait disturbance—Temozolomide—malignant glioma	0.000766	0.00525	CcSEcCtD
Levofloxacin—Respiratory failure—Temozolomide—malignant glioma	0.000761	0.00522	CcSEcCtD
Levofloxacin—Coordination abnormal—Temozolomide—malignant glioma	0.000761	0.00522	CcSEcCtD
Levofloxacin—Pulmonary embolism—Temozolomide—malignant glioma	0.000747	0.00513	CcSEcCtD
Levofloxacin—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.000747	0.00513	CcSEcCtD
Levofloxacin—Vaginal inflammation—Temozolomide—malignant glioma	0.000747	0.00513	CcSEcCtD
Levofloxacin—Depressed level of consciousness—Carmustine—malignant glioma	0.000747	0.00512	CcSEcCtD
Levofloxacin—Urinary incontinence—Carmustine—malignant glioma	0.000747	0.00512	CcSEcCtD
Levofloxacin—Skin exfoliation—Carmustine—malignant glioma	0.000738	0.00506	CcSEcCtD
Levofloxacin—Candida infection—Carmustine—malignant glioma	0.000738	0.00506	CcSEcCtD
Levofloxacin—Lomefloxacin—TOP2A—malignant glioma	0.000736	0.108	CrCbGaD
Levofloxacin—Neuropathy—Carmustine—malignant glioma	0.000726	0.00498	CcSEcCtD
Levofloxacin—Influenza like illness—Temozolomide—malignant glioma	0.000726	0.00498	CcSEcCtD
Levofloxacin—Urinary incontinence—Temozolomide—malignant glioma	0.000722	0.00495	CcSEcCtD
Levofloxacin—Depressed level of consciousness—Temozolomide—malignant glioma	0.000722	0.00495	CcSEcCtD
Levofloxacin—Candida infection—Temozolomide—malignant glioma	0.000713	0.00489	CcSEcCtD
Levofloxacin—Skin exfoliation—Temozolomide—malignant glioma	0.000713	0.00489	CcSEcCtD
Levofloxacin—Vaginal infection—Temozolomide—malignant glioma	0.000706	0.00484	CcSEcCtD
Levofloxacin—Neuropathy—Temozolomide—malignant glioma	0.000702	0.00481	CcSEcCtD
Levofloxacin—Aplastic anaemia—Temozolomide—malignant glioma	0.000702	0.00481	CcSEcCtD
Levofloxacin—Neoplasm—Carmustine—malignant glioma	0.000699	0.0048	CcSEcCtD
Levofloxacin—Dry eye—Temozolomide—malignant glioma	0.00069	0.00473	CcSEcCtD
Levofloxacin—Neoplasm—Temozolomide—malignant glioma	0.000676	0.00463	CcSEcCtD
Levofloxacin—Abnormal vision—Carmustine—malignant glioma	0.000674	0.00463	CcSEcCtD
Levofloxacin—Sepsis—Carmustine—malignant glioma	0.000671	0.0046	CcSEcCtD
Levofloxacin—Abnormal vision—Temozolomide—malignant glioma	0.000652	0.00447	CcSEcCtD
Levofloxacin—Phlebitis—Carmustine—malignant glioma	0.000652	0.00447	CcSEcCtD
Levofloxacin—Thrombophlebitis—Carmustine—malignant glioma	0.000648	0.00445	CcSEcCtD
Levofloxacin—Diabetes mellitus—Carmustine—malignant glioma	0.000645	0.00443	CcSEcCtD
Levofloxacin—Swelling—Carmustine—malignant glioma	0.000636	0.00436	CcSEcCtD
Levofloxacin—Ear pain—Temozolomide—malignant glioma	0.000636	0.00436	CcSEcCtD
Levofloxacin—Ofloxacin—TOP2A—malignant glioma	0.000629	0.0924	CrCbGaD
Levofloxacin—Thrombophlebitis—Temozolomide—malignant glioma	0.000627	0.0043	CcSEcCtD
Levofloxacin—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000624	0.00428	CcSEcCtD
Levofloxacin—Eye pain—Carmustine—malignant glioma	0.000622	0.00427	CcSEcCtD
Levofloxacin—Gastroenteritis—Temozolomide—malignant glioma	0.000612	0.0042	CcSEcCtD
Levofloxacin—Ciprofloxacin—TOP2A—malignant glioma	0.000608	0.0893	CrCbGaD
Levofloxacin—Deafness—Temozolomide—malignant glioma	0.000606	0.00416	CcSEcCtD
Levofloxacin—Vascular purpura—Temozolomide—malignant glioma	0.000606	0.00416	CcSEcCtD
Levofloxacin—Hepatic failure—Temozolomide—malignant glioma	0.000604	0.00414	CcSEcCtD
Levofloxacin—Eye pain—Temozolomide—malignant glioma	0.000601	0.00412	CcSEcCtD
Levofloxacin—Amnesia—Carmustine—malignant glioma	0.000597	0.0041	CcSEcCtD
Levofloxacin—Hot flush—Temozolomide—malignant glioma	0.00058	0.00398	CcSEcCtD
Levofloxacin—Amnesia—Temozolomide—malignant glioma	0.000577	0.00396	CcSEcCtD
Levofloxacin—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000575	0.00394	CcSEcCtD
Levofloxacin—Menopausal symptoms—Temozolomide—malignant glioma	0.000575	0.00394	CcSEcCtD
Levofloxacin—Thirst—Temozolomide—malignant glioma	0.00057	0.00391	CcSEcCtD
Levofloxacin—Hyponatraemia—Carmustine—malignant glioma	0.000564	0.00387	CcSEcCtD
Levofloxacin—Purpura—Temozolomide—malignant glioma	0.000563	0.00386	CcSEcCtD
Levofloxacin—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000561	0.00385	CcSEcCtD
Levofloxacin—Diplopia—Carmustine—malignant glioma	0.000561	0.00385	CcSEcCtD
Levofloxacin—Diplopia—Temozolomide—malignant glioma	0.000542	0.00372	CcSEcCtD
Levofloxacin—Face oedema—Carmustine—malignant glioma	0.000542	0.00372	CcSEcCtD
Levofloxacin—Affect lability—Temozolomide—malignant glioma	0.000534	0.00366	CcSEcCtD
Levofloxacin—Ataxia—Carmustine—malignant glioma	0.000528	0.00362	CcSEcCtD
Levofloxacin—Face oedema—Temozolomide—malignant glioma	0.000524	0.00359	CcSEcCtD
Levofloxacin—Mood swings—Temozolomide—malignant glioma	0.000514	0.00353	CcSEcCtD
Levofloxacin—Hypokalaemia—Carmustine—malignant glioma	0.000511	0.0035	CcSEcCtD
Levofloxacin—Norfloxacin—TOP2A—malignant glioma	0.00051	0.0749	CrCbGaD
Levofloxacin—Ataxia—Temozolomide—malignant glioma	0.00051	0.0035	CcSEcCtD
Levofloxacin—Dehydration—Temozolomide—malignant glioma	0.000504	0.00346	CcSEcCtD
Levofloxacin—Dry skin—Temozolomide—malignant glioma	0.000497	0.00341	CcSEcCtD
Levofloxacin—Hypokalaemia—Temozolomide—malignant glioma	0.000494	0.00339	CcSEcCtD
Levofloxacin—Breast disorder—Temozolomide—malignant glioma	0.00049	0.00336	CcSEcCtD
Levofloxacin—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000488	0.00335	CcSEcCtD
Levofloxacin—Dysphagia—Carmustine—malignant glioma	0.000485	0.00333	CcSEcCtD
Levofloxacin—Abdominal distension—Temozolomide—malignant glioma	0.000472	0.00324	CcSEcCtD
Levofloxacin—Dysphagia—Temozolomide—malignant glioma	0.000469	0.00322	CcSEcCtD
Levofloxacin—Pancytopenia—Carmustine—malignant glioma	0.000461	0.00316	CcSEcCtD
Levofloxacin—Sweating increased—Temozolomide—malignant glioma	0.000457	0.00313	CcSEcCtD
Levofloxacin—Neutropenia—Carmustine—malignant glioma	0.000454	0.00311	CcSEcCtD
Levofloxacin—Bronchitis—Temozolomide—malignant glioma	0.000451	0.00309	CcSEcCtD
Levofloxacin—Pancytopenia—Temozolomide—malignant glioma	0.000445	0.00305	CcSEcCtD
Levofloxacin—Neutropenia—Temozolomide—malignant glioma	0.000438	0.00301	CcSEcCtD
Levofloxacin—Dysuria—Temozolomide—malignant glioma	0.000438	0.00301	CcSEcCtD
Levofloxacin—Hyperglycaemia—Carmustine—malignant glioma	0.000438	0.003	CcSEcCtD
Levofloxacin—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000436	0.00299	CcSEcCtD
Levofloxacin—Pneumonia—Carmustine—malignant glioma	0.000435	0.00298	CcSEcCtD
Levofloxacin—Pollakiuria—Temozolomide—malignant glioma	0.000433	0.00297	CcSEcCtD
Levofloxacin—Erectile dysfunction—Temozolomide—malignant glioma	0.000432	0.00296	CcSEcCtD
Levofloxacin—Photosensitivity reaction—Temozolomide—malignant glioma	0.000428	0.00294	CcSEcCtD
Levofloxacin—Renal failure—Carmustine—malignant glioma	0.000425	0.00292	CcSEcCtD
Levofloxacin—Weight decreased—Temozolomide—malignant glioma	0.000424	0.00291	CcSEcCtD
Levofloxacin—Neuropathy peripheral—Carmustine—malignant glioma	0.000424	0.00291	CcSEcCtD
Levofloxacin—Hyperglycaemia—Temozolomide—malignant glioma	0.000423	0.0029	CcSEcCtD
Levofloxacin—Stomatitis—Carmustine—malignant glioma	0.000422	0.00289	CcSEcCtD
Levofloxacin—Pneumonia—Temozolomide—malignant glioma	0.00042	0.00288	CcSEcCtD
Levofloxacin—Infestation NOS—Temozolomide—malignant glioma	0.000418	0.00287	CcSEcCtD
Levofloxacin—Infestation—Temozolomide—malignant glioma	0.000418	0.00287	CcSEcCtD
Levofloxacin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000414	0.00284	CcSEcCtD
Levofloxacin—Neuropathy peripheral—Temozolomide—malignant glioma	0.00041	0.00281	CcSEcCtD
Levofloxacin—Stomatitis—Temozolomide—malignant glioma	0.000407	0.0028	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Temozolomide—malignant glioma	0.000395	0.00271	CcSEcCtD
Levofloxacin—Sinusitis—Temozolomide—malignant glioma	0.000392	0.00269	CcSEcCtD
Levofloxacin—Haemoglobin—Carmustine—malignant glioma	0.00039	0.00268	CcSEcCtD
Levofloxacin—Haemorrhage—Carmustine—malignant glioma	0.000388	0.00266	CcSEcCtD
Levofloxacin—Hallucination—Carmustine—malignant glioma	0.000386	0.00265	CcSEcCtD
Levofloxacin—Hypoaesthesia—Carmustine—malignant glioma	0.000386	0.00265	CcSEcCtD
Levofloxacin—Oedema peripheral—Carmustine—malignant glioma	0.000383	0.00262	CcSEcCtD
Levofloxacin—Connective tissue disorder—Carmustine—malignant glioma	0.000382	0.00262	CcSEcCtD
Levofloxacin—Haemoglobin—Temozolomide—malignant glioma	0.000377	0.00259	CcSEcCtD
Levofloxacin—Haemorrhage—Temozolomide—malignant glioma	0.000375	0.00257	CcSEcCtD
Levofloxacin—Hepatitis—Temozolomide—malignant glioma	0.000375	0.00257	CcSEcCtD
Levofloxacin—Visual impairment—Carmustine—malignant glioma	0.000374	0.00257	CcSEcCtD
Levofloxacin—Hallucination—Temozolomide—malignant glioma	0.000373	0.00256	CcSEcCtD
Levofloxacin—Hypoaesthesia—Temozolomide—malignant glioma	0.000373	0.00256	CcSEcCtD
Levofloxacin—Pharyngitis—Temozolomide—malignant glioma	0.000372	0.00255	CcSEcCtD
Levofloxacin—Urinary tract disorder—Temozolomide—malignant glioma	0.000371	0.00254	CcSEcCtD
Levofloxacin—Oedema peripheral—Temozolomide—malignant glioma	0.00037	0.00254	CcSEcCtD
Levofloxacin—Connective tissue disorder—Temozolomide—malignant glioma	0.000369	0.00253	CcSEcCtD
Levofloxacin—Urethral disorder—Temozolomide—malignant glioma	0.000368	0.00252	CcSEcCtD
Levofloxacin—Eye disorder—Carmustine—malignant glioma	0.000363	0.00249	CcSEcCtD
Levofloxacin—Visual impairment—Temozolomide—malignant glioma	0.000362	0.00248	CcSEcCtD
Levofloxacin—Flushing—Carmustine—malignant glioma	0.00036	0.00247	CcSEcCtD
Levofloxacin—Erythema multiforme—Temozolomide—malignant glioma	0.000355	0.00243	CcSEcCtD
Levofloxacin—Eye disorder—Temozolomide—malignant glioma	0.000351	0.00241	CcSEcCtD
Levofloxacin—Tinnitus—Temozolomide—malignant glioma	0.00035	0.0024	CcSEcCtD
Levofloxacin—Flushing—Temozolomide—malignant glioma	0.000348	0.00239	CcSEcCtD
Levofloxacin—Cardiac disorder—Temozolomide—malignant glioma	0.000348	0.00239	CcSEcCtD
Levofloxacin—Arrhythmia—Carmustine—malignant glioma	0.000347	0.00238	CcSEcCtD
Levofloxacin—Alopecia—Carmustine—malignant glioma	0.000343	0.00235	CcSEcCtD
Levofloxacin—Angiopathy—Temozolomide—malignant glioma	0.00034	0.00234	CcSEcCtD
Levofloxacin—Mental disorder—Carmustine—malignant glioma	0.00034	0.00233	CcSEcCtD
Levofloxacin—Immune system disorder—Temozolomide—malignant glioma	0.000339	0.00233	CcSEcCtD
Levofloxacin—Mediastinal disorder—Temozolomide—malignant glioma	0.000338	0.00232	CcSEcCtD
Levofloxacin—Erythema—Carmustine—malignant glioma	0.000338	0.00232	CcSEcCtD
Levofloxacin—Malnutrition—Carmustine—malignant glioma	0.000338	0.00232	CcSEcCtD
Levofloxacin—Chills—Temozolomide—malignant glioma	0.000337	0.00231	CcSEcCtD
Levofloxacin—Alopecia—Temozolomide—malignant glioma	0.000332	0.00227	CcSEcCtD
Levofloxacin—Mental disorder—Temozolomide—malignant glioma	0.000329	0.00226	CcSEcCtD
Levofloxacin—Back pain—Carmustine—malignant glioma	0.000327	0.00224	CcSEcCtD
Levofloxacin—Malnutrition—Temozolomide—malignant glioma	0.000327	0.00224	CcSEcCtD
Levofloxacin—Erythema—Temozolomide—malignant glioma	0.000327	0.00224	CcSEcCtD
Levofloxacin—Dysgeusia—Temozolomide—malignant glioma	0.00032	0.00219	CcSEcCtD
Levofloxacin—Vision blurred—Carmustine—malignant glioma	0.000319	0.00219	CcSEcCtD
Levofloxacin—Tremor—Carmustine—malignant glioma	0.000317	0.00217	CcSEcCtD
Levofloxacin—Back pain—Temozolomide—malignant glioma	0.000316	0.00217	CcSEcCtD
Levofloxacin—Anaemia—Carmustine—malignant glioma	0.000312	0.00214	CcSEcCtD
Levofloxacin—Agitation—Carmustine—malignant glioma	0.000311	0.00213	CcSEcCtD
Levofloxacin—Vision blurred—Temozolomide—malignant glioma	0.000308	0.00211	CcSEcCtD
Levofloxacin—Tremor—Temozolomide—malignant glioma	0.000306	0.0021	CcSEcCtD
Levofloxacin—Ill-defined disorder—Temozolomide—malignant glioma	0.000303	0.00208	CcSEcCtD
Levofloxacin—Leukopenia—Carmustine—malignant glioma	0.000303	0.00208	CcSEcCtD
Levofloxacin—Anaemia—Temozolomide—malignant glioma	0.000302	0.00207	CcSEcCtD
Levofloxacin—Agitation—Temozolomide—malignant glioma	0.0003	0.00206	CcSEcCtD
Levofloxacin—Angioedema—Temozolomide—malignant glioma	0.000299	0.00205	CcSEcCtD
Levofloxacin—Malaise—Temozolomide—malignant glioma	0.000295	0.00202	CcSEcCtD
Levofloxacin—Vertigo—Temozolomide—malignant glioma	0.000294	0.00201	CcSEcCtD
Levofloxacin—Leukopenia—Temozolomide—malignant glioma	0.000292	0.00201	CcSEcCtD
Levofloxacin—Hypertension—Carmustine—malignant glioma	0.000292	0.002	CcSEcCtD
Levofloxacin—Palpitations—Temozolomide—malignant glioma	0.000289	0.00198	CcSEcCtD
Levofloxacin—Chest pain—Carmustine—malignant glioma	0.000288	0.00197	CcSEcCtD
Levofloxacin—Myalgia—Carmustine—malignant glioma	0.000288	0.00197	CcSEcCtD
Levofloxacin—Anxiety—Carmustine—malignant glioma	0.000287	0.00197	CcSEcCtD
Levofloxacin—Cough—Temozolomide—malignant glioma	0.000285	0.00196	CcSEcCtD
Levofloxacin—Hypertension—Temozolomide—malignant glioma	0.000282	0.00193	CcSEcCtD
Levofloxacin—Confusional state—Carmustine—malignant glioma	0.000278	0.00191	CcSEcCtD
Levofloxacin—Arthralgia—Temozolomide—malignant glioma	0.000278	0.00191	CcSEcCtD
Levofloxacin—Myalgia—Temozolomide—malignant glioma	0.000278	0.00191	CcSEcCtD
Levofloxacin—Anxiety—Temozolomide—malignant glioma	0.000277	0.0019	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000276	0.00189	CcSEcCtD
Levofloxacin—Oedema—Carmustine—malignant glioma	0.000276	0.00189	CcSEcCtD
Levofloxacin—Discomfort—Temozolomide—malignant glioma	0.000275	0.00188	CcSEcCtD
Levofloxacin—Infection—Carmustine—malignant glioma	0.000274	0.00188	CcSEcCtD
Levofloxacin—Dry mouth—Temozolomide—malignant glioma	0.000272	0.00187	CcSEcCtD
Levofloxacin—Thrombocytopenia—Carmustine—malignant glioma	0.00027	0.00185	CcSEcCtD
Levofloxacin—Tachycardia—Carmustine—malignant glioma	0.000269	0.00185	CcSEcCtD
Levofloxacin—Confusional state—Temozolomide—malignant glioma	0.000269	0.00184	CcSEcCtD
Levofloxacin—Anaphylactic shock—Temozolomide—malignant glioma	0.000267	0.00183	CcSEcCtD
Levofloxacin—Oedema—Temozolomide—malignant glioma	0.000267	0.00183	CcSEcCtD
Levofloxacin—Infection—Temozolomide—malignant glioma	0.000265	0.00182	CcSEcCtD
Levofloxacin—Anorexia—Carmustine—malignant glioma	0.000263	0.0018	CcSEcCtD
Levofloxacin—Nervous system disorder—Temozolomide—malignant glioma	0.000261	0.00179	CcSEcCtD
Levofloxacin—Thrombocytopenia—Temozolomide—malignant glioma	0.000261	0.00179	CcSEcCtD
Levofloxacin—Skin disorder—Temozolomide—malignant glioma	0.000259	0.00178	CcSEcCtD
Levofloxacin—Hypotension—Carmustine—malignant glioma	0.000258	0.00177	CcSEcCtD
Levofloxacin—Hyperhidrosis—Temozolomide—malignant glioma	0.000258	0.00177	CcSEcCtD
Levofloxacin—Anorexia—Temozolomide—malignant glioma	0.000254	0.00174	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000251	0.00172	CcSEcCtD
Levofloxacin—Insomnia—Carmustine—malignant glioma	0.00025	0.00171	CcSEcCtD
Levofloxacin—Paraesthesia—Carmustine—malignant glioma	0.000248	0.0017	CcSEcCtD
Levofloxacin—Dyspnoea—Carmustine—malignant glioma	0.000246	0.00169	CcSEcCtD
Levofloxacin—Somnolence—Carmustine—malignant glioma	0.000245	0.00168	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000243	0.00167	CcSEcCtD
Levofloxacin—Insomnia—Temozolomide—malignant glioma	0.000241	0.00165	CcSEcCtD
Levofloxacin—Decreased appetite—Carmustine—malignant glioma	0.00024	0.00165	CcSEcCtD
Levofloxacin—Paraesthesia—Temozolomide—malignant glioma	0.000239	0.00164	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Carmustine—malignant glioma	0.000238	0.00163	CcSEcCtD
Levofloxacin—Dyspnoea—Temozolomide—malignant glioma	0.000238	0.00163	CcSEcCtD
Levofloxacin—Somnolence—Temozolomide—malignant glioma	0.000237	0.00163	CcSEcCtD
Levofloxacin—Pain—Carmustine—malignant glioma	0.000236	0.00162	CcSEcCtD
Levofloxacin—Constipation—Carmustine—malignant glioma	0.000236	0.00162	CcSEcCtD
Levofloxacin—Dyspepsia—Temozolomide—malignant glioma	0.000235	0.00161	CcSEcCtD
Levofloxacin—Decreased appetite—Temozolomide—malignant glioma	0.000232	0.00159	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00023	0.00158	CcSEcCtD
Levofloxacin—Fatigue—Temozolomide—malignant glioma	0.00023	0.00158	CcSEcCtD
Levofloxacin—Pain—Temozolomide—malignant glioma	0.000228	0.00156	CcSEcCtD
Levofloxacin—Constipation—Temozolomide—malignant glioma	0.000228	0.00156	CcSEcCtD
Levofloxacin—Feeling abnormal—Carmustine—malignant glioma	0.000227	0.00156	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Carmustine—malignant glioma	0.000226	0.00155	CcSEcCtD
Levofloxacin—Feeling abnormal—Temozolomide—malignant glioma	0.00022	0.00151	CcSEcCtD
Levofloxacin—Abdominal pain—Carmustine—malignant glioma	0.000218	0.0015	CcSEcCtD
Levofloxacin—Body temperature increased—Carmustine—malignant glioma	0.000218	0.0015	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000218	0.0015	CcSEcCtD
Levofloxacin—Urticaria—Temozolomide—malignant glioma	0.000212	0.00145	CcSEcCtD
Levofloxacin—Body temperature increased—Temozolomide—malignant glioma	0.000211	0.00145	CcSEcCtD
Levofloxacin—Abdominal pain—Temozolomide—malignant glioma	0.000211	0.00145	CcSEcCtD
Levofloxacin—Hypersensitivity—Carmustine—malignant glioma	0.000203	0.00139	CcSEcCtD
Levofloxacin—Asthenia—Carmustine—malignant glioma	0.000198	0.00136	CcSEcCtD
Levofloxacin—Hypersensitivity—Temozolomide—malignant glioma	0.000196	0.00135	CcSEcCtD
Levofloxacin—Asthenia—Temozolomide—malignant glioma	0.000191	0.00131	CcSEcCtD
Levofloxacin—Diarrhoea—Carmustine—malignant glioma	0.000189	0.00129	CcSEcCtD
Levofloxacin—Pruritus—Temozolomide—malignant glioma	0.000189	0.00129	CcSEcCtD
Levofloxacin—Dizziness—Carmustine—malignant glioma	0.000182	0.00125	CcSEcCtD
Levofloxacin—Diarrhoea—Temozolomide—malignant glioma	0.000182	0.00125	CcSEcCtD
Levofloxacin—Dizziness—Temozolomide—malignant glioma	0.000176	0.00121	CcSEcCtD
Levofloxacin—Vomiting—Carmustine—malignant glioma	0.000175	0.0012	CcSEcCtD
Levofloxacin—Rash—Carmustine—malignant glioma	0.000174	0.00119	CcSEcCtD
Levofloxacin—Dermatitis—Carmustine—malignant glioma	0.000174	0.00119	CcSEcCtD
Levofloxacin—Headache—Carmustine—malignant glioma	0.000173	0.00119	CcSEcCtD
Levofloxacin—Vomiting—Temozolomide—malignant glioma	0.00017	0.00116	CcSEcCtD
Levofloxacin—Rash—Temozolomide—malignant glioma	0.000168	0.00115	CcSEcCtD
Levofloxacin—Dermatitis—Temozolomide—malignant glioma	0.000168	0.00115	CcSEcCtD
Levofloxacin—Headache—Temozolomide—malignant glioma	0.000167	0.00115	CcSEcCtD
Levofloxacin—Nausea—Carmustine—malignant glioma	0.000164	0.00112	CcSEcCtD
Levofloxacin—Nausea—Temozolomide—malignant glioma	0.000158	0.00109	CcSEcCtD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	5.49e-05	0.00222	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—CYP2B6—malignant glioma	5.42e-05	0.00219	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—PDGFRA—malignant glioma	5.41e-05	0.00218	CbGpPWpGaD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	5.38e-05	0.00218	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—HLA-B—malignant glioma	5.37e-05	0.00217	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—CYP2B6—malignant glioma	5.34e-05	0.00216	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—H3F3A—malignant glioma	5.34e-05	0.00216	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	5.33e-05	0.00215	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	5.3e-05	0.00214	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	5.29e-05	0.00214	CbGpPWpGaD
Levofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	5.17e-05	0.00209	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—BCHE—malignant glioma	5.15e-05	0.00208	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—YWHAE—malignant glioma	5.14e-05	0.00208	CbGpPWpGaD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	5.12e-05	0.00207	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	5.03e-05	0.00203	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	5.02e-05	0.00203	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—HLA-A—malignant glioma	4.98e-05	0.00201	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	4.95e-05	0.002	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	4.93e-05	0.00199	CbGpPWpGaD
Levofloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	4.89e-05	0.00198	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	4.88e-05	0.00197	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—SLC6A3—malignant glioma	4.84e-05	0.00196	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	4.77e-05	0.00193	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	4.7e-05	0.0019	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	4.63e-05	0.00187	CbGpPWpGaD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—malignant glioma	4.56e-05	0.00184	CbGpPWpGaD
Levofloxacin—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	4.5e-05	0.00182	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	4.48e-05	0.00181	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	4.43e-05	0.00179	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—malignant glioma	4.32e-05	0.00175	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—CD80—malignant glioma	4.2e-05	0.0017	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	4.18e-05	0.00169	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	4.16e-05	0.00168	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	4.12e-05	0.00167	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	4.1e-05	0.00166	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	4.09e-05	0.00165	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	4.09e-05	0.00165	CbGpPWpGaD
Levofloxacin—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	4.06e-05	0.00164	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	4.05e-05	0.00164	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—PTEN—malignant glioma	3.99e-05	0.00161	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	3.92e-05	0.00158	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—BRCA2—malignant glioma	3.9e-05	0.00157	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDKN2B—malignant glioma	3.86e-05	0.00156	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—GSTT1—malignant glioma	3.8e-05	0.00153	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	3.76e-05	0.00152	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	3.74e-05	0.00151	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—malignant glioma	3.73e-05	0.00151	CbGpPWpGaD
Levofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	3.66e-05	0.00148	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	3.64e-05	0.00147	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	3.63e-05	0.00147	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	3.62e-05	0.00146	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	3.57e-05	0.00144	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—TFRC—malignant glioma	3.57e-05	0.00144	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—PTGS1—malignant glioma	3.56e-05	0.00144	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—COX8A—malignant glioma	3.5e-05	0.00142	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.46e-05	0.0014	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—BRAF—malignant glioma	3.43e-05	0.00139	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.38e-05	0.00137	CbGpPWpGaD
Levofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	3.38e-05	0.00137	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—RTEL1—malignant glioma	3.33e-05	0.00135	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—BIRC5—malignant glioma	3.33e-05	0.00135	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—IFNG—malignant glioma	3.32e-05	0.00134	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.28e-05	0.00133	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	3.27e-05	0.00132	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TERT—malignant glioma	3.23e-05	0.0013	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.22e-05	0.0013	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.19e-05	0.00129	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	3.19e-05	0.00129	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	3.18e-05	0.00128	CbGpPWpGaD
Levofloxacin—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	3.14e-05	0.00127	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.12e-05	0.00126	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—CXCL8—malignant glioma	3.09e-05	0.00125	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	3.09e-05	0.00125	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ASMT—malignant glioma	2.98e-05	0.0012	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—TFRC—malignant glioma	2.98e-05	0.0012	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	2.96e-05	0.0012	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—IL1B—malignant glioma	2.96e-05	0.0012	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—CASP3—malignant glioma	2.95e-05	0.00119	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—IL2—malignant glioma	2.95e-05	0.00119	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	2.94e-05	0.00119	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.93e-05	0.00119	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—GSTT1—malignant glioma	2.93e-05	0.00118	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	2.9e-05	0.00117	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—MDM2—malignant glioma	2.87e-05	0.00116	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—RAF1—malignant glioma	2.86e-05	0.00116	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.84e-05	0.00115	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	2.84e-05	0.00115	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—BCAN—malignant glioma	2.8e-05	0.00113	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	2.78e-05	0.00112	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	2.78e-05	0.00112	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—PTGS1—malignant glioma	2.75e-05	0.00111	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	2.74e-05	0.00111	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—TP53—malignant glioma	2.73e-05	0.0011	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	2.67e-05	0.00108	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—RTEL1—malignant glioma	2.66e-05	0.00108	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	2.64e-05	0.00107	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	2.64e-05	0.00107	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—GSTP1—malignant glioma	2.63e-05	0.00106	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—BRAF—malignant glioma	2.63e-05	0.00106	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	2.62e-05	0.00106	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	2.6e-05	0.00105	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	2.6e-05	0.00105	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—VEGFA—malignant glioma	2.51e-05	0.00101	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—RAF1—malignant glioma	2.5e-05	0.00101	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—malignant glioma	2.47e-05	0.000998	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.4e-05	0.000969	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	2.38e-05	0.000963	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—IDH2—malignant glioma	2.26e-05	0.000913	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDKN2A—malignant glioma	2.21e-05	0.000892	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—MDM2—malignant glioma	2.2e-05	0.00089	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—RAF1—malignant glioma	2.19e-05	0.000887	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—TNF—malignant glioma	2.15e-05	0.000868	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MDM2—malignant glioma	2.14e-05	0.000866	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	2.14e-05	0.000863	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP2B6—malignant glioma	2.12e-05	0.000858	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	2.07e-05	0.000836	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—RTEL1—malignant glioma	2.05e-05	0.00083	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	2.05e-05	0.000826	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—GSTP1—malignant glioma	2.03e-05	0.000821	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	2e-05	0.00081	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—IDH1—malignant glioma	1.94e-05	0.000785	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—COX8A—malignant glioma	1.91e-05	0.000774	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	1.9e-05	0.000769	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—SPHK1—malignant glioma	1.88e-05	0.000759	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	1.85e-05	0.000746	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP2C18—malignant glioma	1.84e-05	0.000744	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	1.84e-05	0.000744	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	1.74e-05	0.000704	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—malignant glioma	1.67e-05	0.000676	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	1.65e-05	0.000668	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	1.63e-05	0.000658	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ASMT—malignant glioma	1.63e-05	0.000658	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	1.63e-05	0.000658	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	1.62e-05	0.000656	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	1.61e-05	0.000649	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	1.57e-05	0.000635	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—BCAN—malignant glioma	1.53e-05	0.000619	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—COX8A—malignant glioma	1.53e-05	0.000618	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MYC—malignant glioma	1.5e-05	0.000605	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	1.49e-05	0.000604	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTT1—malignant glioma	1.49e-05	0.000602	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	1.46e-05	0.000589	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	1.42e-05	0.000575	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	1.42e-05	0.000572	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTGS1—malignant glioma	1.4e-05	0.000564	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	1.37e-05	0.000554	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.37e-05	0.000552	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ASMT—malignant glioma	1.3e-05	0.000525	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—BCHE—malignant glioma	1.3e-05	0.000524	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—SLC5A5—malignant glioma	1.28e-05	0.000518	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.27e-05	0.000513	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	1.24e-05	0.0005	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—IDH2—malignant glioma	1.23e-05	0.000499	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TP53—malignant glioma	1.23e-05	0.000497	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—BCAN—malignant glioma	1.22e-05	0.000494	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—RAF1—malignant glioma	1.18e-05	0.000477	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—COX8A—malignant glioma	1.18e-05	0.000477	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP2B6—malignant glioma	1.16e-05	0.000469	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.14e-05	0.00046	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.11e-05	0.00045	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—IDH1—malignant glioma	1.06e-05	0.000429	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.06e-05	0.000428	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.05e-05	0.000425	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTP1—malignant glioma	1.03e-05	0.000417	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SPHK1—malignant glioma	1.03e-05	0.000415	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP2C18—malignant glioma	1.01e-05	0.000406	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CAT—malignant glioma	1e-05	0.000406	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ASMT—malignant glioma	1e-05	0.000405	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—IDH2—malignant glioma	9.85e-06	0.000398	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	9.66e-06	0.000391	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—NCOR1—malignant glioma	9.48e-06	0.000383	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—BCAN—malignant glioma	9.43e-06	0.000381	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	9.35e-06	0.000378	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	9.29e-06	0.000375	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP2B6—malignant glioma	9.26e-06	0.000374	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—IDH1—malignant glioma	8.47e-06	0.000342	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SPHK1—malignant glioma	8.2e-06	0.000331	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTT1—malignant glioma	8.13e-06	0.000329	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP2C18—malignant glioma	8.03e-06	0.000324	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	7.89e-06	0.000319	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CAV1—malignant glioma	7.73e-06	0.000312	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTGS1—malignant glioma	7.62e-06	0.000308	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—IDH2—malignant glioma	7.6e-06	0.000307	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.57e-06	0.000306	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP2B6—malignant glioma	7.15e-06	0.000289	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—BCHE—malignant glioma	7.09e-06	0.000286	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CG—malignant glioma	7.04e-06	0.000285	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SLC5A5—malignant glioma	7e-06	0.000283	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.9e-06	0.000279	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PPARG—malignant glioma	6.8e-06	0.000275	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.66e-06	0.000269	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—IDH1—malignant glioma	6.54e-06	0.000264	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTT1—malignant glioma	6.49e-06	0.000262	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	6.45e-06	0.000261	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SPHK1—malignant glioma	6.33e-06	0.000256	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP2C18—malignant glioma	6.2e-06	0.00025	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CD—malignant glioma	6.19e-06	0.00025	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTGS1—malignant glioma	6.09e-06	0.000246	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.06e-06	0.000245	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—BCHE—malignant glioma	5.66e-06	0.000229	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTP1—malignant glioma	5.64e-06	0.000228	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SLC5A5—malignant glioma	5.59e-06	0.000226	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CAT—malignant glioma	5.49e-06	0.000222	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CB—malignant glioma	5.4e-06	0.000218	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTGS2—malignant glioma	5.35e-06	0.000216	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.28e-06	0.000214	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.24e-06	0.000212	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—NCOR1—malignant glioma	5.18e-06	0.000209	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTT1—malignant glioma	5.01e-06	0.000203	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTGS1—malignant glioma	4.7e-06	0.00019	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTEN—malignant glioma	4.66e-06	0.000188	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.57e-06	0.000185	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTP1—malignant glioma	4.5e-06	0.000182	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CAT—malignant glioma	4.38e-06	0.000177	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—BCHE—malignant glioma	4.37e-06	0.000176	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.31e-06	0.000174	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CAV1—malignant glioma	4.22e-06	0.000171	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—NCOR1—malignant glioma	4.14e-06	0.000167	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CG—malignant glioma	3.85e-06	0.000155	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PPARG—malignant glioma	3.71e-06	0.00015	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTP1—malignant glioma	3.47e-06	0.00014	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CD—malignant glioma	3.38e-06	0.000137	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CAT—malignant glioma	3.38e-06	0.000137	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CAV1—malignant glioma	3.37e-06	0.000136	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CA—malignant glioma	3.29e-06	0.000133	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.22e-06	0.00013	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—NCOR1—malignant glioma	3.19e-06	0.000129	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CG—malignant glioma	3.07e-06	0.000124	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PPARG—malignant glioma	2.96e-06	0.00012	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CB—malignant glioma	2.95e-06	0.000119	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTGS2—malignant glioma	2.92e-06	0.000118	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.7e-06	0.000109	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—AKT1—malignant glioma	2.69e-06	0.000109	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CAV1—malignant glioma	2.6e-06	0.000105	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTEN—malignant glioma	2.55e-06	0.000103	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.37e-06	9.58e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CB—malignant glioma	2.35e-06	9.51e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTGS2—malignant glioma	2.33e-06	9.42e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PPARG—malignant glioma	2.29e-06	9.24e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.08e-06	8.42e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTEN—malignant glioma	2.03e-06	8.22e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.82e-06	7.34e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTGS2—malignant glioma	1.8e-06	7.27e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CA—malignant glioma	1.8e-06	7.26e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTEN—malignant glioma	1.57e-06	6.34e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—AKT1—malignant glioma	1.47e-06	5.93e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.43e-06	5.8e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—AKT1—malignant glioma	1.17e-06	4.74e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.11e-06	4.47e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—AKT1—malignant glioma	9.05e-07	3.66e-05	CbGpPWpGaD
